BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 19371326)

  • 1. Drug targets for traumatic brain injury from poly(ADP-ribose)polymerase pathway modulation.
    Besson VC
    Br J Pharmacol; 2009 Jul; 157(5):695-704. PubMed ID: 19371326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of neuronal nitric oxide synthase-mediated activation of poly(ADP-ribose) polymerase in traumatic brain injury: neuroprotection by 3-aminobenzamide.
    Hortobágyi T; Görlach C; Benyó Z; Lacza Z; Hortobágyi S; Wahl M; Harkany T
    Neuroscience; 2003; 121(4):983-90. PubMed ID: 14580948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deleterious poly(ADP-ribose)polymerase-1 pathway activation in traumatic brain injury in rat.
    Besson VC; Croci N; Boulu RG; Plotkine M; Marchand-Verrecchia C
    Brain Res; 2003 Oct; 989(1):58-66. PubMed ID: 14519512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidative stress in brain ischemia.
    Love S
    Brain Pathol; 1999 Jan; 9(1):119-31. PubMed ID: 9989455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Poly (adp-ribose) polymerase inhibitors as potential therapeutic agents in stroke and neurotrauma.
    Komjáti K; Besson VC; Szabó C
    Curr Drug Targets CNS Neurol Disord; 2005 Apr; 4(2):179-94. PubMed ID: 15857303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction between inducible nitric oxide synthase and poly(ADP-ribose) polymerase in focal ischemic brain injury.
    Park EM; Cho S; Frys K; Racchumi G; Zhou P; Anrather J; Iadecola C
    Stroke; 2004 Dec; 35(12):2896-901. PubMed ID: 15514191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ischemic nitric oxide and poly (ADP-ribose) polymerase-1 in cerebral ischemia: male toxicity, female protection.
    McCullough LD; Zeng Z; Blizzard KK; Debchoudhury I; Hurn PD
    J Cereb Blood Flow Metab; 2005 Apr; 25(4):502-12. PubMed ID: 15689952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nitrosative stress and pharmacological modulation of heart failure.
    Pacher P; Schulz R; Liaudet L; Szabó C
    Trends Pharmacol Sci; 2005 Jun; 26(6):302-10. PubMed ID: 15925705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poly(ADP-ribosyl)ation basally activated by DNA strand breaks reflects glutamate-nitric oxide neurotransmission.
    Pieper AA; Blackshaw S; Clements EE; Brat DJ; Krug DK; White AJ; Pinto-Garcia P; Favit A; Conover JR; Snyder SH; Verma A
    Proc Natl Acad Sci U S A; 2000 Feb; 97(4):1845-50. PubMed ID: 10677544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective actions of PJ34, a poly(ADP-ribose)polymerase inhibitor, on the blood-brain barrier after traumatic brain injury in mice.
    Tao X; Chen X; Hao S; Hou Z; Lu T; Sun M; Liu B
    Neuroscience; 2015 Apr; 291():26-36. PubMed ID: 25668593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure and function of poly(ADP-ribose) polymerase-1: role in oxidative stress-related pathologies.
    Virág L
    Curr Vasc Pharmacol; 2005 Jul; 3(3):209-14. PubMed ID: 16026317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel and potent poly(ADP-ribose) polymerase-1 inhibitor, FR247304 (5-chloro-2-[3-(4-phenyl-3,6-dihydro-1(2H)-pyridinyl)propyl]-4(3H)-quinazolinone), attenuates neuronal damage in in vitro and in vivo models of cerebral ischemia.
    Iwashita A; Tojo N; Matsuura S; Yamazaki S; Kamijo K; Ishida J; Yamamoto H; Hattori K; Matsuoka N; Mutoh S
    J Pharmacol Exp Ther; 2004 Aug; 310(2):425-36. PubMed ID: 15075382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poly(ADP-ribose) Polymerase (PARP) and PARP Inhibitors: Mechanisms of Action and Role in Cardiovascular Disorders.
    Henning RJ; Bourgeois M; Harbison RD
    Cardiovasc Toxicol; 2018 Dec; 18(6):493-506. PubMed ID: 29968072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of Peroxynitrite-Induced Activation of Poly(ADP-Ribose) Polymerase (PARP) in Circulatory Shock and Related Pathological Conditions.
    Islam BU; Habib S; Ali SA; Moinuddin ; Ali A
    Cardiovasc Toxicol; 2017 Oct; 17(4):373-383. PubMed ID: 27990620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of nitrosative stress and poly(ADP-ribose) polymerase activation in myocardial reperfusion injury.
    Szabó G; Bährle S
    Curr Vasc Pharmacol; 2005 Jul; 3(3):215-20. PubMed ID: 16026318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of NADPH oxidase and neuronal nitric oxide synthase in zinc-induced poly(ADP-ribose) polymerase activation and cell death in cortical culture.
    Kim YH; Koh JY
    Exp Neurol; 2002 Oct; 177(2):407-18. PubMed ID: 12429187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PARP-1 inhibition attenuates neuronal loss, microglia activation and neurological deficits after traumatic brain injury.
    Stoica BA; Loane DJ; Zhao Z; Kabadi SV; Hanscom M; Byrnes KR; Faden AI
    J Neurotrauma; 2014 Apr; 31(8):758-72. PubMed ID: 24476502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Visible light may directly induce nuclear DNA damage triggering the death pathway in RGC-5 cells.
    Li GY; Fan B; Ma TH
    Mol Vis; 2011; 17():3279-89. PubMed ID: 22194654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poly(ADP-ribose) polymerase-1 modulation of in vivo response of brain hypoxia-inducible factor-1 to hypoxia/reoxygenation is mediated by nitric oxide and factor inhibiting HIF.
    Martínez-Romero R; Cañuelo A; Martínez-Lara E; Javier Oliver F; Cárdenas S; Siles E
    J Neurochem; 2009 Oct; 111(1):150-9. PubMed ID: 19656264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of poly(ADP-ribose) synthetase in inflammation and ischaemia-reperfusion.
    Szabó C; Dawson VL
    Trends Pharmacol Sci; 1998 Jul; 19(7):287-98. PubMed ID: 9703762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.